Equities

Bayer AG

0P6S:LSE

Bayer AG

  • Price (EUR)45.61
  • Today's Change0.96 / 2.15%
  • Shares traded1.62m
  • 1 Year change114.31%
  • Beta0.8697
Data delayed at least 20 minutes, as of Feb 06 2026 15:00 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Bayer AG had relatively flat revenues (47.64bn to 46.61bn), though the company grew net income from a loss of 2.94bn to a smaller loss of 2.55bn.
Gross margin56.35%
Net profit margin-0.38%
Operating margin4.20%
Return on assets-0.16%
Return on equity-0.66%
Return on investment-0.22%
More ▼

Cash flow in EURView more

In 2024, Bayer AG did not generate a significant amount of cash. However, the company earned 7.37bn from its operations for a Cash Flow Margin of 15.80%. In addition the company generated 164.00m cash from investing, though they paid out 7.18bn more in financing than they received.
Cash flow per share3.46
Price/Cash flow per share13.23
Book value per share30.11
Tangible book value per share-18.80
More ▼

Balance sheet in EURView more

Bayer AG has a Debt to Total Capital ratio of 57.17%, a lower figure than the previous year's 120.00%.
Current ratio1.14
Quick ratio0.7096
Total debt/total equity1.34
Total debt/total capital0.5717
More ▼

Growth rates in EUR

SmartText is unavailable
Div yield(5 year avg)3.37%
Div growth rate (5 year)-47.66%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
77.50
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.